We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

115 hedge funds and large institutions have $168M invested in Inovio Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more call options, than puts

Call options by funds: $4.75M | Put options by funds: $3.45M

12% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 33

8% more capital invested

Capital invested by funds: $156M → $168M (+$12M)

0.45% less ownership

Funds ownership: 3.21% → 2.76% (-0.45%)

7% less funds holding

Funds holding: 123 → 115 (-8)

24% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 25

Holders
115
Holders Change
-8
Holders Change %
-6.5%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
37
Reduced
33
Closed
25
Calls
$4.75M
Puts
$3.45M
Net Calls
+$1.3M
Net Calls Change
-$835K

Top Buyers

1
DCM
Dialectic Capital Management
Connecticut
+$1.61M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.27M
3
RFC
Russell Frank Company
Washington
+$1.07M
4
EI
EAM Investors
California
+$712K
5
GC
Globeflex Capital
California
+$646K

Top Sellers

1
SM
Sabby Management
Florida
-$4.16M
2
Millennium Management
Millennium Management
New York
-$3.88M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.64M
4
State Street
State Street
Massachusetts
-$2.39M
5
IG
ING Group
Netherlands
-$2.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$24.4M +$243K +3,144 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$23.3M +$1.27M +16,428 +8%
State Street
3
State Street
Massachusetts
$18M -$2.39M -30,996 -15%
WA
4
Wasatch Advisors
Utah
$16.3M -$289K -3,743 -2%
BIT
5
BlackRock Institutional Trust
California
$16.3M -$10.6K -137 -0.1%
Northern Trust
6
Northern Trust
Illinois
$7.24M +$49.4K +640 +0.9%
Morgan Stanley
7
Morgan Stanley
New York
$5.18M -$1.49M -19,240 -28%
SIP
8
Stoneridge Investment Partners
Pennsylvania
$3.4M -$1.19M -15,358 -32%
PAM
9
Panagora Asset Management
Massachusetts
$3.19M +$150K +1,940 +7%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$2.98M +$84.2K +1,090 +4%
New York State Common Retirement Fund
11
New York State Common Retirement Fund
New York
$2.77M -$513K -6,639 -20%
BG
12
Bellevue Group
Switzerland
$2.31M +$1.7M +22,083 New
BIM
13
BlackRock Investment Management
Delaware
$2.28M +$36.4K +472 +2%
TCIM
14
TIAA CREF Investment Management
New York
$2.18M – – –
DCM
15
Dialectic Capital Management
Connecticut
$2.18M +$1.61M +20,833 New
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1.84M -$411K -5,318 -23%
Creative Planning
17
Creative Planning
Kansas
$1.49M +$106K +1,367 +11%
RFC
18
Russell Frank Company
Washington
$1.45M +$1.07M +13,887 New
PI
19
Putnam Investments
Massachusetts
$1.41M – – –
EA
20
Emerald Advisers
Pennsylvania
$1.41M -$1.65M -21,425 -61%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$1.32M +$122K +1,579 +14%
American Century Companies
22
American Century Companies
Missouri
$1.31M +$83.6K +1,083 +9%
TA
23
Teachers Advisors
New York
$1.28M – – –
UBS Group
24
UBS Group
Switzerland
$1.16M -$128K -1,658 -13%
ERSOT
25
Employees Retirement System of Texas
Texas
$1.08M – – –
1
2 3 4 5

INO Hedge Fund Activity: Q1 2016 in Review

115 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q1 2016, worth a combined $168M — up 7.7% from $156M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of INO and 19 opened new positions — a net loss of 6 holders — while 33 trimmed existing stakes and 37 added.

The largest buyer was Dialectic Capital Management, opening a new position worth an estimated $1.61M. The largest seller was Sabby Management, exiting entirely with an estimated $4.16M sold.

  • 115 institutional investors held Inovio Pharmaceuticals (INO) as of Q1 2016, down from 123 in Q4 2015.
  • Funds reported $168M of Inovio Pharmaceuticals stock for Q1 2016, up 7.7% quarter-over-quarter.
  • 19 funds opened new Inovio Pharmaceuticals positions in Q1 2016 and 25 closed out, a net change of -6 holders.
  • The largest Inovio Pharmaceuticals buyer in Q1 2016 was Dialectic Capital Management, an estimated $1.61M added.
  • The largest Inovio Pharmaceuticals seller in Q1 2016 was Sabby Management, an estimated $4.16M sold.

Based on aggregated 13F filings for Q1 2016.